相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Adam Nagy et al.
SCIENTIFIC REPORTS (2018)
Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma
Julien Bollard et al.
GUT (2017)
PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements
Huaiyu Mi et al.
NUCLEIC ACIDS RESEARCH (2017)
Aldehyde Dehydrogenase-2 (ALDH2) Opposes Hepatocellular Carcinoma Progression by Regulating AMP-Activated Protein Kinase Signaling in Mice
Guojun Hou et al.
HEPATOLOGY (2017)
FOXK2, regulted by miR-1271-5p, promotes cell growth and indicates unfavorable prognosis in hepatocellular carcinoma
Mei-Fang Lin et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2017)
Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma
Lindsey N. Kent et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity In Vitro
Sandra Rebouissou et al.
CLINICAL CANCER RESEARCH (2017)
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Adrian Ally et al.
CELL (2017)
Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma
Zakir Khan et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2017)
H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma
Ting Liu et al.
TUMOR BIOLOGY (2016)
Expression of Maternal Embryonic Leucine Zipper Kinase (MELK) Correlates to Malignant Potentials in Hepatocellular Carcinoma
Kiyokazu Hiwatashi et al.
ANTICANCER RESEARCH (2016)
Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer
A. Blythe Ryerson et al.
CANCER (2016)
NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2
Xiaofeng Liu et al.
EMBO REPORTS (2016)
Hepatocellular Carcinoma Repression by TNFα-Mediated Synergistic Lethal Effect of Mitosis Defect-Induced Senescence and Cell Death Sensitization
Dan Li et al.
HEPATOLOGY (2016)
Associations of components of PTEN/AKT/mTOR pathway with cancer stem cell markers and prognostic value of these biomarkers in hepatocellular carcinoma
Rujuan Su et al.
HEPATOLOGY RESEARCH (2016)
Role of Osteopontin in Liver Diseases
Yankai Wen et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
Genetic profiling of hepatocellular carcinoma using next-generation sequencing
Kornelius Schulze et al.
JOURNAL OF HEPATOLOGY (2016)
The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma
Meiling Cui et al.
TUMOR BIOLOGY (2016)
Clinicopathological relevance of kinesin family member 18A expression in invasive breast cancer
Mai Kasahara et al.
ONCOLOGY LETTERS (2016)
Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy
Weiguo Zhang et al.
NATURE COMMUNICATIONS (2016)
HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models1
Mariacarla Andreozzi et al.
NEOPLASIA (2016)
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
Jessica Zucman-Rossi et al.
GASTROENTEROLOGY (2015)
Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma
Shawky Abdelhamid Fouad et al.
HEPATITIS MONTHLY (2015)
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma
Weijia Liao et al.
ONCOTARGET (2015)
Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma
Wen Hu et al.
ONCOTARGET (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
DEP Domain Containing 1 is a Novel Diagnostic Marker and Prognostic Predictor for Hepatocellular Carcinoma
Sheng-Guang Yuan et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Differential Expression of IQGAP1/2 in Hepatocellular Carcinoma and its Relationship with Clinical Outcomes
Fa-Da Xia et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
GSK-3β-Regulated N-Acetyltransferase 10 Is Involved in Colorectal Cancer Invasion
Hong Zhang et al.
CLINICAL CANCER RESEARCH (2014)
Upregulation of E2F transcription factor 3 is associated with poor prognosis in hepatocellular carcinoma
Xiaoyun Zeng et al.
ONCOLOGY REPORTS (2014)
miR-122 Targets Pyruvate Kinase M2 and Affects Metabolism of Hepatocellular Carcinoma
Angela M. Liu et al.
PLOS ONE (2014)
Chemical Inhibition of NAT10 Corrects Defects of Laminopathic Cells
Delphine Larrieu et al.
SCIENCE (2014)
Cytoskeleton-associated protein 2 is a potential predictive marker for risk of early and extensive recurrence of hepatocellular carcinoma after operative resection
Tatsuya Hayashi et al.
SURGERY (2014)
Expression of survivin mRNA in gallbladder cancer: a diagnostic and prognostic marker?
Jaya Nigam et al.
TUMOR BIOLOGY (2014)
Comparison osteopontin vs AFP for the diagnosis of HCC: A meta-analysis
Hao-Guang Wan et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2014)
High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma
Weijia Liao et al.
ONCOTARGET (2014)
Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies
Lunxiu Qin
FRONTIERS OF MEDICINE (2014)
The E2F Transcription Factor 1 Transactives Stathmin 1 in Hepatocellular Carcinoma
Yi-Ling Chen et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Low cyclin F expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis
Jia Fu et al.
CANCER SCIENCE (2013)
The burden of liver disease in Europe: A review of available epidemiological data
Martin Blachier et al.
JOURNAL OF HEPATOLOGY (2013)
Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma
Jeng-Wei Lu et al.
MEDICAL ONCOLOGY (2013)
Overexpression of CENP-H as a novel prognostic biomarker for human hepatocellular carcinoma progression and patient survival
Guifang Lu et al.
ONCOLOGY REPORTS (2013)
Meta-Analysis: Prognostic Value of Survivin in Patients with Hepatocellular Carcinoma
Jin Long Liu et al.
PLOS ONE (2013)
Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance
Michael Heise et al.
BMC CANCER (2012)
Why Your New Cancer Biomarker May Never Work: Recurrent Patterns and Remarkable Diversity in Biomarker Failures
Scott E. Kern
CANCER RESEARCH (2012)
Molecular mechanisms of sorafenib action in liver cancer cells
Melchiorre Cervello et al.
CELL CYCLE (2012)
Killing cells by targeting mitosis
E. Manchado et al.
CELL DEATH AND DIFFERENTIATION (2012)
Kinetochores and disease: keeping microtubule dynamics in check!
Samuel F. Bakhoum et al.
CURRENT OPINION IN CELL BIOLOGY (2012)
CIP2A Is Highly Expressed in Hepatocellular Carcinoma and Predicts Poor Prognosis
Hui He et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2012)
Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli
Joan Fernando et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection
Li Weng et al.
MOLECULAR CANCER (2012)
Cancer drug's survivin suppression called into question
David Holmes
NATURE MEDICINE (2012)
Identification of ADH4 as a novel and potential prognostic marker in hepatocellular carcinoma
Rong-Rong Wei et al.
MEDICAL ONCOLOGY (2012)
Prognostic Value of Survivin in Patients with Non-Small Cell Lung Carcinoma: A Systematic Review with Meta-Analysis
Lou Qian Zhang et al.
PLOS ONE (2012)
Molecular Targeted Therapies in Hepatocellular Carcinoma
Shinji Tanaka et al.
SEMINARS IN ONCOLOGY (2012)
Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers
Dong-Xing Cao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
FOXM1 expression predicts the prognosis in hepatocellular carcinoma patients after orthotopic liver transplantation combined with the Milan criteria
Hongcheng Sun et al.
CANCER LETTERS (2011)
Combining Clinical, Pathology, and Gene Expression Data to Predict Recurrence of Hepatocellular Carcinoma
Augusto Villanueva et al.
GASTROENTEROLOGY (2011)
Intracellular osteopontin (iOPN) and immunity
Makoto Inoue et al.
IMMUNOLOGIC RESEARCH (2011)
Gene-expression signature of vascular invasion in hepatocellular carcinoma
Beatriz Minguez et al.
JOURNAL OF HEPATOLOGY (2011)
Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis
Koji Kitamura et al.
JOURNAL OF HEPATOLOGY (2011)
Gene signatures in hepatocellular carcinoma (HCC)
Ourania M. Andrisani et al.
SEMINARS IN CANCER BIOLOGY (2011)
Misregulation of Scm3p/HJURP Causes Chromosome Instability in Saccharomyces cerevisiae and Human Cells
Prashant K. Mishra et al.
PLOS GENETICS (2011)
CKS1B Overexpression Implicates Clinical Aggressiveness of Hepatocellular Carcinomas but Not p27Kip1 Protein Turnover: an Independent Prognosticator with Potential p27Kip1-Independent Oncogenic Attributes?
Ching-Wen Huang et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
S. Mallett et al.
BRITISH JOURNAL OF CANCER (2010)
Hepatocellular carcinoma: a global view
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Centromere Protein H Is a Novel Prognostic Marker for Human Nonsmall Cell Lung Cancer Progression and Overall Patient Survival
Wen-Ting Liao et al.
CANCER (2009)
The clinicopathological significance of BUBR1 overexpression in hepatocellular carcinoma
A-W Liu et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Overexpression of polo-like kinase1 predicts a poor prognosis in hepatocellular carcinoma patients
Zi-Li He et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Survivin: Key regulator of mitosis and apoptosis and novel target for cancer therapeutics
Alain C. Mita et al.
CLINICAL CANCER RESEARCH (2008)
Osteopontin: Role in immune regulation and stress responses
Kathryn X. Wang et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
The kinesin-8 motor Kif18A suppresses kinetochore movements to control mitotic chromosome alignment
Jason Stumpff et al.
DEVELOPMENTAL CELL (2008)
Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma
Shu-Hui Zhang et al.
HUMAN PATHOLOGY (2008)
Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma
Satoshi Kuboki et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma
G-Y Chau et al.
HISTOPATHOLOGY (2007)
Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival
Wen-Ting Liao et al.
CLINICAL CANCER RESEARCH (2007)
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Sandrine Boyault et al.
HEPATOLOGY (2007)
Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma
R-H Yuan et al.
JOURNAL OF PATHOLOGY (2006)
Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis
Tsutomu Fujii et al.
HEPATOLOGY (2006)
Predictors of long-term survival after liver transplantation for hepatocellular carcinoma
C Zavaglia et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Centromere protein H is up-regulated in primary human colorectal cancer and its overexpression induces aneuploidy
T Tomonaga et al.
CANCER RESEARCH (2005)
Expression of c-kit protooncogene in human hepatocellular carcinoma
CY Chung et al.
CANCER LETTERS (2005)
Overexpression and amplification of Aurora-A in hepatocellular carcinoma
YM Jeng et al.
CLINICAL CANCER RESEARCH (2004)
Regulation of survivin function by Hsp90
P Fortugno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Molecular cloning of a novel human gene encoding histone acetyltransferase-like protein involved in transcriptional activation of hTERT
JJ Lv et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Centromeres and kinetochores: From epigenetics to mitotic checkpoint signaling
DW Cleveland et al.
CELL (2003)
Liver transplantation for hepatocellular carcinoma: A proposal of a prognostic scoring system
S Iwatsuki et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2000)
分享论文
